Cyxone appoints Carl-Magnus Högerkorp as COO strengthening immunology core competencies
Cyxone today announces that Carl-Magnus Högerkorp is appointed new COO in the company from May 20th, 2021. With broad experience from work within the field of immunology and autoimmune diseases, as well as extensive international experience and previous management roles in the biotech sector, Carl-Magnus is an important part of Cyxone’s continued ambition to strengthen and develop the company.Carl-Magnus holds a PhD in immunology from Lund University, as well as an MBA from Lund University School of Economics and Management. He started his career with a postdoc position at the Vaccine